The Fathom Platform
Piton’s platform harnesses cutting-edge data science and biological insight to tackle complex diseases rooted in microbiome-host interactions. By integrating systems biology, multi-omic evidence, and machine learning, we uncover actionable insights that drive therapeutic innovation across the discovery pipeline.
What we deliver
Piton’s unique capabilities are realizing the untapped potential of microbiome-focused therapeutics. The company is a leader in the development of a new category of therapeutic modalities of orally delivered, small and large molecules that precisely target specific disease-causing mechanisms.
Causal Mechanism Discovery
Go beyond correlation.
Identify the biological pathways, regulatory interactions, and protein functions driving
disease progression or
treatment response.
Target
Prioritization
Pinpoint high-impact intervention points with systems-level reasoning. Our platform ranks druggable targets based on multi-omic evidence and network context.
Drug Discovery & Repurposing
Uncover new therapeutic candidates by linking molecules, mechanisms, and diseases across multi-modal datasets.
Biomarker
Discovery
Reveal novel diagnostic and prognostic biomarkers through integrated data mining and graph-based pattern recognition.
The problem we are solving
Modern biology produces massive amounts of data, but much of it remains siloed, hard to understand, and underutilized. Drug Discovery and clinical decisions are made without a full systems-level view.
Piton’s Fathom Platform transforms this fragmented data into systems-level insights by integrating multi-omics with AI-powered knowledge graphs and predictive modeling.
Integrative multi-omics analysis
We integrate genomics, proteomics, and metabolomics to gain a systems-level understanding of disease by connecting molecular dysfunction, identifying key proteins driving disease processes, and capturing real-time metabolic signatures of cellular activity. This multiomics approach enables precise target identification, supports personalized, mechanism-driven therapeutics, and provides a powerful platform for de-risking early drug development.
Systems integration of multi-modal data
Piton integrates diverse datasets—including patient samples, proprietary cohorts, chemical libraries, scientific publications, biological networks, and curated databases—into a unified systems biology framework. At the core of our platform is a proprietary engine that combines integrative multi-omics analysis, knowledge graphs, large language models, and machine learning to extract deep biological insights. By connecting molecular data with literature and network context, we identify robust biomarkers, uncover novel drug targets, and deliver predictive AI models that drive precision drug discovery.
Learn about Piton’s AI-powered platform
At Piton Therapeutics, we are revolutionizing precision medicine through our state-of-the-art AI-powered platform, unlocking novel small-molecule therapeutics that target the gut-brain axis with unparalleled specificity.